Literature DB >> 9298573

Reproductive history, use of exogenous hormones, and risk of colorectal adenomas.

L A Peipins1, B Newman, R S Sandler.   

Abstract

Evidence suggests a role for reproductive and hormonal factors in the etiology of colorectal cancer. Investigation of adenomas, the presumed precursors of cancer, and reproductive characteristics may place such associations within a particular stage of carcinogenesis. We examined parity, age at first birth, age at menopause, and age at menarche as well as contraceptive and noncontraceptive hormone use in a case-control study of 347 women (115 cases with adenomas and 232 controls) conducted in North Carolina. Using unconditional logistic regression analysis, increasing age at menopause was found to be associated with a reduction in the risk of adenomas [odds ratio (OR), 0.26; 95% confidence interval (CI), 0.10-0.68]. An increased risk for adenomas was found for women undergoing surgical menopause as compared with women undergoing natural menopause (OR, 2.10; 95% CI, 1.05-4.21). Our results suggest a reduced risk of adenomas associated with noncontraceptive hormone use that was limited to a subgroup of women with natural menopause or bilateral oophorectomy (OR, 0.39; 95% CI, 0.15-0.97). No associations were seen between other reproductive characteristics and adenomas. These results suggest protective effects for both endogenous and exogenous female hormones that operate early in the process of carcinogenesis. Alternatively, lifestyle factors or other correlates of exogenous hormone use and delayed menopause could play a role in reduced adenoma risk.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9298573

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  9 in total

1.  Menopausal hormone therapy and risks of colorectal adenomas and cancers in the French E3N prospective cohort: true associations or bias?

Authors:  Sophie Morois; Agnès Fournier; Françoise Clavel-Chapelon; Sylvie Mesrine; Marie-Christine Boutron-Ruault
Journal:  Eur J Epidemiol       Date:  2012-05-29       Impact factor: 8.082

2.  Hormone replacement therapy, oral contraceptive use, and distal large bowel cancer: a population-based case-control study.

Authors:  Millie D Long; Christopher F Martin; Joseph A Galanko; Robert S Sandler
Journal:  Am J Gastroenterol       Date:  2010-03-30       Impact factor: 10.864

Review 3.  Primary prevention of colorectal cancer.

Authors:  Andrew T Chan; Edward L Giovannucci
Journal:  Gastroenterology       Date:  2010-06       Impact factor: 22.682

Review 4.  Dietary, endocrine, and metabolic factors in the development of colorectal cancer.

Authors:  Michele Barone; Katia Lofano; Nicola De Tullio; Raffaele Licinio; Raffaele Licino; Francesca Albano; Alfredo Di Leo
Journal:  J Gastrointest Cancer       Date:  2012-03

5.  Estrogens, phytoestrogens and colorectal neoproliferative lesions.

Authors:  Michele Barone; Sabina Tanzi; Katia Lofano; Maria Principia Scavo; Raffaella Guido; Lucia Demarinis; Maria Beatrice Principi; Antongiulio Bucci; Alfredo Di Leo
Journal:  Genes Nutr       Date:  2008-04       Impact factor: 5.523

6.  A prospective study of oral contraceptive use and colorectal adenomas.

Authors:  Brittany M Charlton; Edward Giovannucci; Charles S Fuchs; Andrew T Chan; Jung Eun Lee; Yin Cao; Stacey A Missmer; Bernard A Rosner; Susan E Hankinson; Walter Willett; Kana Wu; Karin B Michels
Journal:  Cancer Causes Control       Date:  2016-04-28       Impact factor: 2.506

7.  Clinicopathologic distribution of KRAS and BRAF mutations in a Chinese population with colorectal cancer precursor lesions.

Authors:  Chenghao Yi; Yanqing Huang; Xing Yu; Xiaofen Li; Shu Zheng; Kefeng Ding; Jinghong Xu
Journal:  Oncotarget       Date:  2016-03-29

8.  Female hormones and the risk of colorectal neoplasm.

Authors:  Yunho Jung
Journal:  Korean J Intern Med       Date:  2019-08-28       Impact factor: 2.884

9.  Age at menarche and risk of colorectal adenoma.

Authors:  Nam Hee Kim; Jung Ho Park; Dong Il Park; Chong Il Sohn; Kyuyong Choi; Yoon Suk Jung
Journal:  Korean J Intern Med       Date:  2018-05-31       Impact factor: 2.884

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.